Nutanix CLO Awarded 30,430 RSUs as Part of Compensation Package
Nutanix, Inc.
Subscribe to track NTNX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Nutanix CLO Awarded 30,430 RSUs
Company: Nutanix, Inc. (NTNX) Form: 4 | Filed: 2025-11-13 Significance: Low
Insider: Martin Brian Title: Chief Legal Officer | Relationship: Officer
Transaction: • Type: Grant • Shares: 30,430 Restricted Stock Units • Price: $0.00 • Value: $0.00 • Owned After: 30,430 (Derivative Securities)
Key Insight: This is a routine equity grant for an executive, representing a negligible 0.011% of total shares outstanding. The grant vests over four years.
Market Context: Standard executive compensation for a large-cap tech company. This transaction is not expected to impact the market.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Nutanix, Inc. (NTNX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Legal Officer of Nutanix received a routine grant of 30,430 Restricted Stock Units (RSUs) as part of their compensation.
- Market Impact: This is a non-material event with a neutral market impact, representing standard executive compensation practices.
Company Information
| Field | Value |
|---|---|
| Company | Nutanix, Inc. |
| Ticker Symbol | NTNX |
| CIK | 0001618732 |
| Industry | SERVICES-PREPACKAGED SOFTWARE |
Insider Information
| Field | Value |
|---|---|
| Name | Martin Brian |
| CIK | 0001395281 |
| Title/Position | Chief Legal Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-10 |
| Transaction Code | A (Grant) |
| Security Type | Restricted Stock Units |
| Shares Involved | 30,430 |
| Price Per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 30,430 (Derivative Securities) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0.00 |
| % of Market Cap | 0.00% |
| Shares Transacted | 30,430 |
| % of Shares Outstanding | 0.011% |
| Post-Transaction Ownership | 30,430 derivative securities |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Nutanix is a large-cap company with a market capitalization of $19.60 billion. This grant is insignificant in value and size relative to the company's scale.
- Ownership Concentration: This grant establishes the insider's derivative position. The number of shares is minimal compared to the total shares outstanding.
- Dilution Impact: The potential dilution from this grant is 0.011%, which is negligible and a standard cost of retaining executive talent. It will not materially affect existing shareholders.
- Transaction Significance: As a grant with a $0 transaction value and representing a very small fraction of shares outstanding, the significance is low. It is a routine administrative filing for executive compensation.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants are a standard form of compensation and are not indicative of an insider's market sentiment. This is a scheduled, non-market transaction.
Volume & Sentiment
- Expected Volume Impact: None. This is not an open-market transaction and will not affect trading volume.
- Sentiment Indicator: Neutral. The market views such grants as a routine part of business operations.
Additional Context
Transaction Notes
- Vesting Schedule: The filing notes that the RSUs vest in 16 equal quarterly installments over four years, beginning December 15, 2025. This long vesting period aligns the executive's interests with long-term shareholder value.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
